---
title: "NEA PARTNERS 14, L.P. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/a48ecd61-e848-513f-b82b-39c2b0b0a8db
json: https://whiteintel.dev/api/public/dossier/a48ecd61-e848-513f-b82b-39c2b0b0a8db
identifier: sec:0001551531
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# NEA PARTNERS 14, L.P.

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0001551531`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/a48ecd61-e848-513f-b82b-39c2b0b0a8db  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/a48ecd61-e848-513f-b82b-39c2b0b0a8db  

## Ownership & control

### Holdings / subsidiaries

- **L&F ACQUISITION CORP.** (tenpercentowner) — https://whiteintel.dev/entity/6149af0d-22c7-551d-be4a-7748b8e109a6
- **SYNLOGIC, INC.** (tenpercentowner) — https://whiteintel.dev/entity/cb1fffff-5c7c-5391-9033-d8ad77862369
- **OYSTER POINT PHARMA, INC.** (tenpercentowner) — https://whiteintel.dev/entity/5e6eb1ea-5893-580d-adfb-09d9a3272164
- **Enliven Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/a92f7bfe-f722-5087-8729-de9a9c48f28d
- **CASPER SLEEP INC.** (tenpercentowner) — https://whiteintel.dev/entity/c7349ec4-a312-57e3-89ce-f769907c82a4
- **Mersana Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/4edf03d1-5dc7-5d54-bee4-8e5ea9d963bc
- **SURFACE ONCOLOGY, INC.** (tenpercentowner) — https://whiteintel.dev/entity/5dbea9e7-99ee-564a-8db1-1e330fa1db13
- **CHAMPIONS BIOTECHNOLOGY, INC.** (tenpercentowner) — https://whiteintel.dev/entity/fd631fc5-52f5-5b79-ad81-9112f7c07be3
- **Galera Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/d29cee4e-6c7d-5845-98d3-81aef0672b42
- **Adaptimmune Therapeutics PLC** (tenpercentowner) — https://whiteintel.dev/entity/ef384144-24c7-5e0d-b0b8-7ca4452a0960
- **MULESOFT INC** (tenpercentowner) — https://whiteintel.dev/entity/fc275a53-0066-5a03-88fb-5bdd22e9f640
- **TRACON PHARMACEUTICALS INC** (tenpercentowner) — https://whiteintel.dev/entity/6044994f-d336-5d5e-a2be-9adb130d3b19
- **CORTENDO AB** (tenpercentowner) — https://whiteintel.dev/entity/19e0898a-9d27-5dc2-bed4-718ec6b3357a
- **APPIAN CORP** (tenpercentowner) — https://whiteintel.dev/entity/cee95a67-fb98-52ff-a797-1189131c2569
- **INTERLEUKIN GENETICS INC** (tenpercentowner) — https://whiteintel.dev/entity/75be6897-c687-5bfe-b267-5e95ebfc6791
- **Avalo Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/7ab53ad5-4202-5e5d-afb7-054c499320ac
- **LOXO ONCOLOGY, INC.** (tenpercentowner) — https://whiteintel.dev/entity/754008b1-41a4-5108-a53a-ffe8793fb4b5

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **NEA PARTNERS 14, L.P.**. Human view: https://whiteintel.dev/entity/a48ecd61-e848-513f-b82b-39c2b0b0a8db · Structured JSON: https://whiteintel.dev/api/public/dossier/a48ecd61-e848-513f-b82b-39c2b0b0a8db._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._